The relatively recent ease of access to lenalidomide in South Africa has revolutionised multiple myeloma management. Dr Zeenat Moorad expands on this.
Multiple myeloma is a blood cancer that develops from a special type of white blood cell, called a plasma cell, in the bone marrow. Plasma cells are part of the immune system, and make proteins called antibodies (immunoglobulins) that attack and kill bacteria and viruses, protecting against infection.